Docket Room
HCR 134·HI·house

URGING THE HAWAII STATE DIRECTOR OF HEALTH TO ISSUE A STATEWIDE ORDER TO ALLOW FOR THE SALE AND PURCHASE OF NEBULIZED BUDESONIDE WITHOUT A PRESCRIPTION OR CONSULTATION WITH A HEALTHCARE PROVIDER.

In CommitteeFiled Mar 16, 2026
Sponsor: ALCOS
Latest Action

Referred to HLT, CPC, referral sheet 19

Mar 18, 2026

Summary

The concurrent resolution asks the Hawaii State Director of Health to issue a statewide order permitting people to buy nebulized budesonide without a prescription or doctor’s consultation. It also encourages the Board of Pharmacy to set labeling and instruction rules for the product and its nebulizer devices. The measure aims to expand access to a medication the sponsors say can help treat respiratory illnesses like COVID‑19.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HCR 134 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice